Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2025-12-25 @ 12:36 AM
NCT ID:
NCT01502267
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18
* patients who are on the waiting list more than 4 years
* PRA I or II \> 50%
Exclusion Criteria:
* Recent recipients of any live attenuated vaccine(s) within 4 weeks
* Subjects who have received IVIG or B cell depleting agents previously
* Subjects with positive result for viral hepatitis(B,C) or HIV infection
* Subjects with active infection
* Lactating or pregnant females
* Subjects who have history of malignancy in recent 5years
* Subjects who have experience of treatment for the psychiatric problem in recent 6months
* Subjects who have hematologic abnormality (Hb \< 7g/dL, Platelet \< 100,000/mm3, AST/ALT \> 80IU)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01502267
Study Brief:
Protocol Section:
NCT01502267